Skip to main content

Berinert 1500 IU injectable

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

Doctor
5.0(38)

Andrei Popov

General medicinePain medicine7 years of experience

Dr. Andrei Popov is a General Practitioner with specialized training in chronic pain. He provides online consultations for adult patients in Spain and other European countries.

Dr. Popov understands that seeking help with weight-related concerns or pain that has persisted for months can be difficult. Many patients come to him after trying different approaches without feeling truly heard. During the consultation, the doctor creates a comfortable and supportive, non-judgmental environment where the patient’s medical history can be discussed in detail, questions can be answered, and the next steps can be decided together.

Weight Management and Metabolic Health

Dr. Popov can help assess overweight, obesity, and related conditions such as hypertension, diabetes, or metabolic disorders. During the consultation, the patient’s medical history, test results, current medications, and previous treatments will be reviewed.

If you would like to learn about possible medication options or have already started treatment, the doctor can assess your situation, review the effectiveness and tolerability of the therapy, and clearly explain its benefits, potential risks, and alternatives.

Not every patient requires the same treatment. A consultation does not guarantee a prescription — it provides an objective medical assessment and a plan tailored to your individual situation.

Pain and General Medicine

You can also consult Dr. Popov regarding:

* chronic pain, migraines, neuralgia, and fibromyalgia;

* back, neck, lower back, or joint pain;

* hypertension, diabetes, and follow-up of chronic conditions;

* review of test results, medical reports, and current treatment;

* preventive medicine and a second medical opinion.

How the Consultation Works

The video consultation lasts up to 30 minutes. The doctor will listen carefully, review the information you provide, and explain the next steps in clear and understandable language.

If additional tests, an in-person consultation, or urgent medical care are required, the doctor will inform you directly.

Dr. Popov’s goal is to make sure the patient feels heard and leaves the consultation with a clear understanding of their condition and the next steps they can take.

Book a video appointment
€86
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use BERINERT 1500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION

Contents of the leaflet

  1. Introduction
  2. What is Berinert and what is it used for
  3. What you need to know before you use Berinert
  4. How to use Berinert
  5. Possible side effects
  6. Storage of Berinert
  7. Contents of the pack and other information

Introduction

Package Leaflet: Information for the User

Berinert 1500 IU

Powder and solvent for solution for injection

Human C1 esterase inhibitor

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the package leaflet

  1. What is Berinert and what is it used for
  2. What you need to know before you use Berinert
  3. How to use Berinert
  4. Possible side effects
  5. Storage of Berinert
  6. Contents of the pack and other information

1. What is Berinert and what is it used for

What is Berinert?

Berinert is presented as a powder and solvent. The prepared solution should be administered by injection into a vein.

Berinert is prepared from human plasma (the liquid part of the blood). The active substance is human C1 esterase inhibitor protein, obtained from plasma.

What is Berinert used for?

Berinert is used for the treatment and preoperative prevention of hereditary angioedema type I and II (HAE, edema = swelling). Hereditary angioedema is a congenital vascular disease. It is not an allergic disease. HAE is caused by insufficient, absent, or defective synthesis of C1 esterase inhibitor, which is an important protein. The disease is characterized by the following symptoms:

  • sudden swelling of hands and feet,
  • sudden swelling of the face with a feeling of tightness,
  • swelling of the eyelids, lips, possible swelling of the larynx (voice organ) with breathing difficulties,
  • swelling of the tongue,
  • colic-like pain in the abdominal region.

Generally, all parts of the body can be affected.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Berinert

The following sections contain information that your doctor should consider before administering Berinert to you.

Do not use Berinert:

  • If you are allergic to C1 esterase inhibitor or any of the other components of this medicine (listed in section 6).

Tell your doctor or pharmacist if you are allergic to any medicine or food.

Warnings and precautions

  • If you have suffered allergic reactions to Berinert in the past. You should take antihistamines and corticosteroids as prophylaxis, if advised by your doctor.
  • When allergic or anaphylactic reactions (severe allergic reaction causing severe breathing difficulties or dizziness) occur. Berinert administration should be discontinued immediately (e.g., by interrupting the injection).
  • If you suffer from laryngeal swelling (laryngeal edema). You should be closely monitored and have emergency treatment ready for use.
  • During use for the treatment of indications and dosages for which the medicine has not been approved (e.g., Capillary Leak Syndrome,CLS). See section 4 "Possible side effects".

Your doctor will carefully weigh the benefit of treatment with Berinert against the risk of these complications.

Viral safety

When administering medicines derived from human blood or plasma, certain measures must be taken to prevent infections from being transmitted to patients. These measures include:

  • careful selection of blood and plasma donors to exclude those who are at risk of being carriers of infectious diseases, and
  • testing for specific virus and infection markers in individual donations and plasma pools.

Manufacturers of these products also include stages in the processing of blood or plasma to eliminate or inactivate viruses. Despite this, when administering medicines derived from human blood or plasma, the possibility of transmitting infectious agents cannot be entirely excluded. This also applies to emerging or unknown viruses or other types of infections.

The measures taken are considered effective for enveloped viruses such as human immunodeficiency virus (HIV, the AIDS virus), hepatitis B virus, hepatitis C virus (liver inflammation), and for non-enveloped viruses such as hepatitis A virus (liver inflammation) and parvovirus B19.

It is possible that your doctor may recommend vaccination against hepatitis A and B if you are treated periodically/repeatedly with human plasma-derived medicines.

It is strongly recommended that each time Berinert is administered, the administration date, batch number, and injected volume be recorded.

Using Berinert with other medicines

  • Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines, including those without a prescription.
  • Berinert should not be mixed with other medicines and diluents in the same syringe.

Pregnancy and breastfeeding

  • If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
  • During pregnancy and breastfeeding, Berinert should only be used if clearly indicated.

Driving and using machines

No studies have been performed on the effects on the ability to drive and use machines.

Berinert contains sodium

Berinert contains less than 23 mg of sodium (1 mmol) per vial; this is essentially "sodium-free".

3. How to use Berinert

Treatment should be initiated and supervised by a doctor experienced in the treatment of C1 esterase inhibitor deficiency.

Dosage

Adults

Treatment of acute angioedema attacks:

20 IU per kilogram of body weight (20 IU/kg body weight).

Preoperative prevention of angioedema attacks:

1000 IU before 6 hours of a medical, dental, or surgical procedure.

Pediatric population

Treatment of acute angioedema attacks:

20 IU per kilogram of body weight (20 IU/kg body weight).

Preoperative prevention of angioedema attacks:

15 to 30 IU per kilogram of body weight (15-30 IU/kg body weight) before 6 hours of a medical, dental, or surgical procedure. The dose should be chosen taking into account the clinical circumstances (e.g., the type of procedure and the severity of the disease).

If you use more Berinert than you should

No cases of overdose have been reported.

Reconstitution and method of administration

Berinert is injected into a vein (intravenous administration), usually by your doctor or nurse. You or your caregiver may also inject Berinert, but only after receiving adequate training. If your doctor decides that you can treat yourself at home, they will give you detailed instructions. You will be given a diary to record each injection administered at home, which you should bring with you every time you visit your doctor. You or your caregiver will be regularly reviewed on how to perform the injections to ensure they are done correctly over time.

General instructions

  • The powder must be dissolved and withdrawn from the vial under aseptic conditions. Use the syringe provided with the product.
  • The prepared solution should be clear and colorless to slightly opalescent. After filtering or transferring the solution (see below), it should be visually checked for particles or discoloration before administration.
  • Do not use the solution if it is visibly cloudy or contains particles or residues.
  • Any unused medicine or material should be disposed of in accordance with local regulations and following the instructions of your doctor.

Reconstitution

Before opening any vial, allow the Berinert powder and solvent to reach room temperature. To do this, you can leave the vials at room temperature for about an hour or hold them in your closed hands for a few minutes. DO NOT expose the vials to direct heat. The vials should not be heated to a temperature above body temperature (37°C).

Carefully remove the protective caps from the solvent vial and the powder vial. Clean the exposed rubber stoppers of both vials with an alcohol swab and let them dry. You can now transfer the solvent to the powder vial using the included administration system (Mix2Vial). Please follow the instructions below:

Cylindrical protective cap with cross-slots at the top and dotted lines outlining its shape 1

  1. Open the Mix2Vial blister by tearing off the seal. Do not remove the Mix2Vial from the blister.

Vial with protective cap and empty vial below, black arrow indicates direction of connection 2

  1. Place the solvent vial on a clean and flat surface and hold it firmly. Hold the Mix2Vial along with the blister and push the blue end down, engaging it with the solvent vial stopper.

Cylindrical device with stacked parts showing a black arrow pointing upwards at the top 3

  1. Carefully remove the blister from the Mix2Vial by holding the edge and pulling vertically upwards. Make sure you only remove the blister and not the Mix2Vial.

Set of stacked cylindrical components showing a medication vial at the base and a cap with multiple parts on top 4

  1. Place the powder vial on a flat and firm surface. Invert the solvent vial with the Mix2Vial attached and push the transparent adapter end down, engaging it with the powder vial stopper. The solvent will automatically transfer to the powder vial.

Medication cartridge with circular connector and detachable cylindrical base 5

  1. With one hand, hold the vial with the product attached to the Mix2Vial and, with the other hand, hold the solvent vial. Carefully unscrew the system, separating it into two pieces.

Discard the solvent vial with the blue Mix2Vial adapter attached.

Medication vial with cap and safety ring, arrow indicating minimum fill level 6

  1. Subject the reconstituted solution vial with the transparent adapter attached to gentle rotational movements until the substance is completely dissolved. Do not shake.

Auto-injector device with transparent cartridge and top button, arrow indicating downward pressure 7

  1. Fill an empty and sterile syringe with air. Use the syringe provided with the product. Holding the solution vial in a vertical position, connect the syringe to the Luer Lock adapter of the Mix2Vial. Inject the air into the solution vial.

Transfer of the reconstituted solution to the syringe and administration

8

  1. Holding the syringe plunger in place, invert the system and slowly draw the solution into the syringe by pulling the plunger back.

9

  1. Once the solution has been transferred to the syringe, firmly hold the syringe body (keeping the plunger down) and disconnect the transparent Mix2Vial adapter from the syringe.

Administration

The solution should be administered by slow intravenous injection (i.v.).

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Contact your doctor immediately

Side effects with Berinert are rare.

The following side effects have been observed rarely (may affect up to 1 in 1,000 people):

  • There is an increased risk of blood clot formation in attempts at prophylactic or therapeutic treatment of Capillary Leak Syndrome (fluid leakage from small blood vessels into tissues), for example, during or after cardiac surgery with extracorporeal circulation. See section 2 "Warnings and precautions".
  • Increased body temperature, as well as burning and itching at the injection site.
  • Hypersensitivity or allergic reactions (such as irregular heartbeat, rapid heartbeat, low blood pressure, skin redness, rash, breathing difficulties, headache, dizziness, feeling sick).

In very rare cases (may affect up to 1 in 10,000 people), allergic reactions can lead to shock.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines and Healthcare Products Agency's website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Berinert

  • Keep this medicine out of the sight and reach of children.
  • Do not use Berinert after the expiry date stated on the label and carton.
  • Do not store above 30°C.
  • Do not freeze.
  • Store the vial in the outer packaging to protect it from light.
  • Berinert does not contain preservatives, so the prepared solution should be used immediately.

If the prepared solution is not administered immediately, it should be used within 8 hours and only stored in the vial.

6. Contents of the pack and other information

Composition of Berinert

The active substance is:

Human C1 esterase inhibitor (1500 IU/vial; after reconstitution with 3 ml of water for injections 500 IU/ml)

For more information, see Section "This information is intended only for healthcare professionals".

The other ingredients are:

Glycine, sodium chloride, sodium citrate.

See the last paragraph of section 2 "Berinert contains sodium".

Solvent:water for injections.

Appearance and packaging

Berinert is presented as a white powder and is supplied with water for injections as a solvent.

The prepared solution should be clear and colorless to slightly opalescent.

Presentation

Box with 1500 IU contains:

1 vial with powder (1500 IU)

1 vial with 3 ml of water for injections

1 transfer device with 20/20 filter

Administration equipment (inner box):

1 single-use 5 ml syringe

1 venipuncture set

2 alcohol swabs

1 dressing

Marketing authorisation holder and manufacturer

CSL Behring GmbH

Emil-von-Behring-Strasse 76

35041 Marburg (Germany)

You can request more information about this medicine from the local representative of the marketing authorisation holder:

CSL Behring S.A.

c/ Tarragona 157, 18th floor

08014 Barcelona

Spain

This medicine is authorised in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:

Berinert 1500 IU Powder and solvent for solution for injection Austria

Berinert 1500 Belgium, Cyprus, Germany, Greece, Luxembourg, Poland, Portugal

Berinert 1500, 500 IU Powder and solvent for solution for injection Bulgaria

Berinert 1500 IU Czech Republic, Slovakia

Berinert Denmark, Italy

Berinert 1500 IU, powder and solvent for solution for injection Finland

Berinert 1500 UI, powder and solvent for solution for injection France

Berinert 1500 NE por és oldószer oldatos injekcióhoz Hungary

Berinert 1500 IU pulver og væske til injeksjons, oppløsning Norway

Berinert 1500, pulbere si solvent pentru solutie injectabila Romania

Berinert 1500 i.e. prašek in vehikel za raztopino za injiciranje Slovenia

Berinert 1500 UI Polvo y disolvente para solución inyectable Spain

Berinert 1500 IE, pulver och vätska till injektionsvätska, lösning Sweden

Berinert 1500 UI powder and solvent for solution for injection United Kingdom

Date of last revision of this leaflet:October 2021

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es

This information is intended only for healthcare professionals

QUALITATIVE AND QUANTITATIVE COMPOSITION

The potency of human C1 esterase inhibitor is expressed in International Units (IU), which is related to the current WHO standard for C1 esterase inhibitor products.

Online doctors for BERINERT 1500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION

Discuss questions about BERINERT 1500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

Doctor
5.0(38)

Andrei Popov

General medicinePain medicine7 years of experience

Dr. Andrei Popov is a General Practitioner with specialized training in chronic pain. He provides online consultations for adult patients in Spain and other European countries.

Dr. Popov understands that seeking help with weight-related concerns or pain that has persisted for months can be difficult. Many patients come to him after trying different approaches without feeling truly heard. During the consultation, the doctor creates a comfortable and supportive, non-judgmental environment where the patient’s medical history can be discussed in detail, questions can be answered, and the next steps can be decided together.

Weight Management and Metabolic Health

Dr. Popov can help assess overweight, obesity, and related conditions such as hypertension, diabetes, or metabolic disorders. During the consultation, the patient’s medical history, test results, current medications, and previous treatments will be reviewed.

If you would like to learn about possible medication options or have already started treatment, the doctor can assess your situation, review the effectiveness and tolerability of the therapy, and clearly explain its benefits, potential risks, and alternatives.

Not every patient requires the same treatment. A consultation does not guarantee a prescription — it provides an objective medical assessment and a plan tailored to your individual situation.

Pain and General Medicine

You can also consult Dr. Popov regarding:

* chronic pain, migraines, neuralgia, and fibromyalgia;

* back, neck, lower back, or joint pain;

* hypertension, diabetes, and follow-up of chronic conditions;

* review of test results, medical reports, and current treatment;

* preventive medicine and a second medical opinion.

How the Consultation Works

The video consultation lasts up to 30 minutes. The doctor will listen carefully, review the information you provide, and explain the next steps in clear and understandable language.

If additional tests, an in-person consultation, or urgent medical care are required, the doctor will inform you directly.

Dr. Popov’s goal is to make sure the patient feels heard and leaves the consultation with a clear understanding of their condition and the next steps they can take.

Book a video appointment
€86
Doctor
5.0(12)

Yevgen Yakovenko

General medicine12 years of experience

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Book a video appointment
€72
Doctor
5.0(3)

Lina Travkina

General medicine13 years of experience

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.

  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.

  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.

  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.

  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.

  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.

  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.

  • Medical advice and follow-up consultations.

  • Test interpretation and diagnostic guidance.

  • Structured support for undiagnosed complaints.

  • Second opinion on diagnoses and treatment plans.

  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.

  • Post-operative recovery support and pain management.

  • Preconception counselling and postpartum support.

  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Book a video appointment
€75
Doctor
5.0(21)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70
Doctor
0.0(0)

Hocine Lokchiri

General medicine21 years of experience

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Book a video appointment
€64

Frequently Asked Questions

BERINERT 1500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

The active ingredient in BERINERT 1500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION is c1-inhibitor, plasma derived. This information helps identify medicines with the same composition but different brand names.

BERINERT 1500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION is manufactured by Csl Behring Gmbh. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether BERINERT 1500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

The prescription is issued by a doctor after assessing your health. In Spain, BERINERT 1500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION is then dispensed in pharmacies with that prescription. An online consultation does not guarantee that a prescription will be issued: the decision always rests with the doctor.

To request a review, you can use Oladoctor:

Other medicines with the same active substance (c1-inhibitor, plasma derived) include BERINERT 2000 IU POWDER AND SOLVENT FOR SUBCUTANEOUS INJECTION SOLUTION, BERINERT 3000 IU POWDER AND SOLVENT FOR SUBCUTANEOUS INJECTION, BERINERT 500 IU POWDER AND SOLVENT FOR INJECTION AND INFUSION SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media